Rottinghaus Scott T.

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
5
Insider Sells Sum
$202,869.15

Insider Activity of Rottinghaus Scott T.

According to the SEC Form 4 filings, Rottinghaus Scott T., being in a position of

  1. Chief Medical Officer at Enanta Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 12811 share for $197,727,
    over all time since 2023-12-05, has bought 0 shares, and sold 13345 shares for $202,869.

The largest sale of all time was on 2024-07-15 and amounted to 5375 shares of Enanta Pharmaceuticals, Inc. for $91,805.

Biography of Rottinghaus Scott T.

No biography is available at this moment.

2024-12-06SaleEnanta Pharmaceuticals, Inc.
ENTA
Chief Medical Officer
866
0.0041%
$8.06$6,980-21.13%
2024-07-15SaleEnanta Pharmaceuticals, Inc.
ENTA
Chief Medical Officer
5,375
0.0355%
$17.08$91,8050%
2024-07-12SaleEnanta Pharmaceuticals, Inc.
ENTA
Chief Medical Officer
2,271
0.0132%
$15.04$34,1560%
2024-07-11SaleEnanta Pharmaceuticals, Inc.
ENTA
Chief Medical Officer
4,299
0.0251%
$15.07$64,7860%
2023-12-05SaleEnanta Pharmaceuticals, Inc.
ENTA
Sr. VP & CMO
534
0.0026%
$9.63$5,142+31.04%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.